← Browse by Condition
Medical Condition

pediatric chronic inflammatory demyelinating polyneuropathy

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT04929236 Phase 3
Recruiting

Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients

Enrollment
30 pts
Location
United States
Sponsor
Octapharma
View Trial →